Abi Barrowcliff

Let's go #hsjawards @cardiorespLTHT Medicines, Pharmacy and Prescribing Initiative of the Year @WYpartnership @DrRaniKhatib

Evidence for MRAs for HF despite ejection fraction. ⬆️ risk of hyperK ⬇️ risk of hypoK

Day 3 and time for Hotline 7. Let's go #ESCCongress

How can weight loss benefit health? #ESCCongress

"Development of obesity is a complex and multifactorial process". One in five adults in ESC member countries have a BMI >30 #ESCCongress

Obicitrapid currently undergoing phase 3 trials. An oral, once daily CEPT inhibitor, that can be used in combination with high intensity statins +/- ezetimibe to reduce LDL-C

More horizon scanning at #ESCCongress volanesorsen (ApoCIII) for reduction of TGs and risk of pancreatitis and olpasiran to reduce Lp(a)

Biologics in dyslipidaemia. Trials underway targeting lowering Lp(a) and Apo-CIII. 2026 for CV outcomes data for inclisiran. Watch this space! #ESCCongress

Incredibly impressed with @MjBPharm for all the expectional work he's put into SDEC. Bringing a piece of that to #CPCongress Plenty of interest and questions. @IamNat @LeedsHospitals @LeedsMedicines @

Catching up with friends at #CPCongress yesterday ❤️ And then some more catching up over food and drinks @PaulWr86 @Almcnal

Come and say hi #cpcongress

Great but challenging discussions around recruitment and retention of pharmacy workforce @UKCPA #ukcpaconf